ArticleThe international journal of neuropsychopharmacology2026
Auricular transcutaneous vagus nerve stimulation stabilizes event segmentation through modulation of working memory representations.
Article in The international journal of neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSegmenting continuous experience into discrete units-event segmentation-is fundamental for situational awareness and adaptive action. Based on Event Segmentation Theory, we used auricular transcutaneous vagus nerve stimulation (atVNS) to test whether the control of event segmentation is moderated by norepinephrine and/or GABAergic systems.
methodsHealthy adults (N = 40) completed a double-blind, counterbalanced experiment in which they watched a narrative movie and indicated perceived event boundaries under active atVNS and sham stimulation while the electroencephalogram (EEG) was recorded. Multivariate pattern analysis (MVPA) quantified the decodability of boundary interval (BI) vs no-boundary interval (NBI), and EEG source reconstruction assessed cortical activation.
resultsRelative to sham, active atVNS reduced the likelihood of segmentation. Converging neurophysiological evidence mirrored this behavioral effect: MVPA revealed lower decoding accuracy for BI and NBI, indicating less distinct neural representational patterns. Source reconstruction showed reduced activation in the prefrontal cortex, a region involved in working memory.
conclusionsAcross behavioral and neural measures, atVNS stabilized ongoing event representation and restricted the updating of the current event working model, consistent with a GABAergic modulation of event segmentation. These findings extend prior work linking atVNS to working memory gating and demonstrate its impact on an ecologically relevant cognitive process-event segmentation. Significance Statement This study tests whether 2 neuromodulators-norepinephrine (NE) and GABA-causally change how people divide continuous experience into meaningful events-a process called event segmentation. We used auricular vagus nerve stimulation (atVNS) to nudge these systems and compared active stimulation with a sham control. Compared to sham, active atVNS reduced the probability of setting event boundaries. In parallel, the brain activity patterns before the moments of segmenting were less distinct from the no-boundary period than in the sham condition, with lower activity in prefrontal regions. Together, these converging behavioral and neural findings indicate that atVNS stabilizes ongoing event representations and restricts the updating of the current event working model, a pattern that more parsimoniously supports a GABAergic inhibitory gating account over an NE arousal account of event segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.